287 related articles for article (PubMed ID: 32953881)
1. Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients.
Cai J; Chen Z; Chen X; Huang H; Lin X; Miao B
Biomed Res Int; 2020; 2020():4264291. PubMed ID: 32953881
[TBL] [Abstract][Full Text] [Related]
2. Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis.
Gong X; Ning B
Technol Cancer Res Treat; 2020; 19():1533033820963578. PubMed ID: 33084528
[TBL] [Abstract][Full Text] [Related]
3. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
4. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
[TBL] [Abstract][Full Text] [Related]
5. Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients.
Cai J; Yang F; Chen X; Huang H; Miao B
Pharmgenomics Pers Med; 2021; 14():797-811. PubMed ID: 34285549
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients.
Bai Z; Li H; Li C; Sheng C; Zhao X
Medicine (Baltimore); 2020 Oct; 99(40):e21503. PubMed ID: 33019382
[TBL] [Abstract][Full Text] [Related]
8. Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer.
Chen G; Qin X; Wang Y; Gao B; Ling M; Yin W; Li Y; Pan B
Cell Cycle; 2022 Aug; 21(16):1684-1696. PubMed ID: 35414328
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential autophagy-associated lncRNA in prostate cancer.
Li J; Du H; Chen W; Qiu M; He P; Ma Z
Aging (Albany NY); 2021 May; 13(9):13153-13165. PubMed ID: 33971627
[TBL] [Abstract][Full Text] [Related]
10. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
12. LASSO‑based Cox‑PH model identifies an 11‑lncRNA signature for prognosis prediction in gastric cancer.
Zhang Y; Li H; Zhang W; Che Y; Bai W; Huang G
Mol Med Rep; 2018 Dec; 18(6):5579-5593. PubMed ID: 30365077
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
14. Molecular network-based identification of competing endogenous RNAs and mRNA signatures that predict survival in prostate cancer.
Xu N; Wu YP; Yin HB; Xue XY; Gou X
J Transl Med; 2018 Oct; 16(1):274. PubMed ID: 30286759
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
16. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer.
Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C
J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
19. Screening of Significant Biomarkers Related to Prognosis of Cervical Cancer and Functional Study Based on lncRNA-associated ceRNA Regulatory Network.
Ding H; Zhang L; Zhang C; Song J; Jiang Y
Comb Chem High Throughput Screen; 2021; 24(3):472-482. PubMed ID: 32729415
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]